SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-004234
Filing Date
2024-02-16
Accepted
2024-02-16 18:25:13
Documents
1
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02162024_110205.html 4  
1 form4-02162024_110205.xml 4 8499
  Complete submission text file 0001415889-24-004234.txt   9948
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SENSEI BIOTHERAPEUTCS, INC. 1405 RESEARCH BLVD., STE. 125 ROCKVILLE MD 20850
Business Address
Colgan Erin (Reporting) CIK: 0001843563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 24649991